Médico. Cardiólogo en el Hospital Clínico Universitario de Valencia.

Valencia, Spain
Joined November 2018
Enrique Santas retweeted
Fully agree with this recently 🇳🇿Consensus statement on the current pharmacological prevention and management of heart failure. Very clear algorithm for drug initiation in HFrEF
2
55
2
137
Show this thread
Enrique Santas retweeted
Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction. Nice review from @JavedButler1 about clinical characteristics, phenotypes , trials results and treatments for HFmrEF and HFpEF. Open access
3
29
1
67
Show this thread
Enrique Santas retweeted
Lamentamos comunicar el fallecimiento del Dr Roberto García Civera. Pionero y referente de la electrofisiología cardiaca. Maestro para muchas generaciones de cardiólogos. Todo nuestro afecto a sus familiares y seres queridos. DEP
3
17
1
60
Enrique Santas retweeted
Los estudios que + le interesan a @SantasEnrique del #ESCcongress son: 〽️DELIVER -Dapagliflozin in HF with Mildly Reduced and Preserved EF 〽️ADVOR -Acetazolamide in acute heart failure 〽️ INVICTUS- Rivaroxaban versus VKA for rheumatic atrial fibrillation invidious.fdn.fr/h1PowqrpWr8
2
6
DIAMOND 💎 trial @ESC_Journals 878 #HFrEF 👥 with hyperK or history of hyperK:patiromer vs placebo ✅ Reduction of serum K with patiromer 👉 35% relative risk ⤵️ in the number of hyperkalemia events 👉 20 👥 with patiromer and 34 with placebo discontinued MRAs (HR=0,64)
1
1
8
Editorial of the Diamond 💎 trial by M Packer in @ESC_Journals 👉 Potassium was lower in the patiromer group, but: * 80% of 👥 did not show K>5,5 in the placebo group —>Safety of following MRA dosing protocols❗️ * >400 👥 treated for 6 months to get a difference of 11 patients
2
5
15
Enrique Santas retweeted
What are the effects of steroidal MRAs (spironolactone & eplerenone) on kidney function in heart failure? After an initial acute decline in GFR, chronic GFR slope is *not* modified by steroidal MRAs Important work led by @mvaduganathan & #JoaoFerreira: onlinelibrary.wiley.com/doi/…
2
21
2
72
Estudio en @ESC_Journals que de nuevo refuerza la asociación entre Lp(a) y estenosis aórtica 👉En este trabajo interesante que la Lp(a) se asocia con la aparición de calcificación valvular, pero no con su progresión academic.oup.com/eurheartj/a…
11
41
Usamos diariamente atorva o rosu a dosis altas. Nos fijamos en el riñón? 🚨Por ficha técnica no usar rosu si FG<30 ml/min(en FDA max 10 mg/dia) Estudio comparando rosu vs atorva en vida real👇 👉 Más riesgo de hematuria, proteinuria o fallo renal con rosu 👉 🚫 en eventos CV
2
34
1
81
✅El comité de la @EMA_News da el visto bueno para la aprobación de Mounjaro (tirzetapida, agonista dual de GLP-1/GIP) de @LillyES 👉 Indicación —> tratamiento de la DM2 añadido a dieta y ejercicio ema.europa.eu/en/medicines/h…
11
30
Enrique Santas retweeted
BIG news: Lp(a) HORIZON is fully recruited (8325 pts)- a 20 yr journey for so many people to get here. The "Lp(a) Hypothesis" gets tested: in pts with optimally treated risk factors, does ⏬⏬ Lp(a) lead to clinical benefit? Will know in 2.5 yrs. $IONS prn.to/3zd4v11
13
37
7
179
Enrique Santas retweeted
⚠️ Heart failure: how to optimize guideline-directed medical therapy‼️ @ESC_Journals @escardio @secardiologia @SACardiologia @clinica_sec academic.oup.com/eurheartj/a…
31
87
Enrique Santas retweeted
Lee el contenido más reciente de la: “ Newsletter de La Sociedad Valenciana de Cardiología - Capítulo 7” getrevue.co/profile/svcardio… @svcardio @santasenrique
5
11